CEO Matthew Madden discusses the increasing need for faster, more reliable internet connections and how DXN are well positioned to service a fast growing market.

DXN Limited (DXN.ASX) is redefining the way modern data centres are constructed and operated, and using Edge Computing to provide solutions to the internet latency issues of today and the future of global internet infrastructure.

Any advice contained within this presentation is general advice and does not consider your objectives, financial situation or needs, and you should consider whether it’s appropriate for you. The information we are giving you is for educational purposes only.

Accurate time of recording, 3 June 2020, 12pm AEST.

CEO and Managing Director Brent Barnes discusses how LBT Innovations are using artificial intelligence and automation to improve the future of healthcasre.

LBT Innovations (LBT.ASX) is a groundbreaking designer of advanced technology solutions for the medical industry. They specialise in bringing advanced medical technologies to market, and their core capabilities include artificial intelligence, image analysis and software engineering solutions that improve medical diagnostic workflows.

Any advice contained within this presentation is general advice and does not consider your objectives, financial situation or needs, and you should consider whether it’s appropriate for you. The information we are giving you is for educational purposes only.

Accurate time of recording, 27 May 2020, 12pm AEST.

Managing Director Scott Williamson discusses the company's proven track record of mineral discovery and corporate success.

Blackstone Minerals (BSX.ASX) is a leading battery and precious metals exploration and development company with an international portfolio of high-quality battery and precious metals exploration projects across South East Asia, North America and Australia.

Any advice contained within this presentation is general advice and does not consider your objectives, financial situation or needs, and you should consider whether it’s appropriate for you. The information we are giving you is for educational purposes only.

Accurate time of recording, 27 May 2020, 12pm AEST.

CEO Steven Yatomi-Clarke discusses how Prescient Therapeutics (PTX.ASX) are addressing the biggest problems in the most exciting area of oncology.

Prescient Therapeutics is focused on developing novel, personalised therapies against a range of cancers. Prescient’s universal CAR-T and targeted therapies are both personalised medicine approaches that seek to improve patient outcomes and provide new tools for clinicians in combating cancer.

Any advice contained within this presentation is general advice and does not consider your objectives, financial situation or needs, and you should consider whether it’s appropriate for you. The information we are giving you is for educational purposes only.

Accurate time of recording, 27 May 2020, 12pm AEST.